JP2023545517A5 - - Google Patents

Info

Publication number
JP2023545517A5
JP2023545517A5 JP2023523050A JP2023523050A JP2023545517A5 JP 2023545517 A5 JP2023545517 A5 JP 2023545517A5 JP 2023523050 A JP2023523050 A JP 2023523050A JP 2023523050 A JP2023523050 A JP 2023523050A JP 2023545517 A5 JP2023545517 A5 JP 2023545517A5
Authority
JP
Japan
Application number
JP2023523050A
Other languages
Japanese (ja)
Other versions
JP2023545517A (ja
JPWO2022082059A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/055302 external-priority patent/WO2022082059A1/en
Publication of JP2023545517A publication Critical patent/JP2023545517A/ja
Publication of JPWO2022082059A5 publication Critical patent/JPWO2022082059A5/ja
Publication of JP2023545517A5 publication Critical patent/JP2023545517A5/ja
Pending legal-status Critical Current

Links

JP2023523050A 2020-10-16 2021-10-15 キメラ受容体およびその使用方法 Pending JP2023545517A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063092736P 2020-10-16 2020-10-16
US63/092,736 2020-10-16
US202163151483P 2021-02-19 2021-02-19
US63/151,483 2021-02-19
PCT/US2021/055302 WO2022082059A1 (en) 2020-10-16 2021-10-15 Chimeric receptors and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2023545517A JP2023545517A (ja) 2023-10-30
JPWO2022082059A5 JPWO2022082059A5 (https=) 2024-10-18
JP2023545517A5 true JP2023545517A5 (https=) 2024-10-18

Family

ID=81209346

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023523050A Pending JP2023545517A (ja) 2020-10-16 2021-10-15 キメラ受容体およびその使用方法

Country Status (8)

Country Link
EP (1) EP4228682A4 (https=)
JP (1) JP2023545517A (https=)
KR (1) KR20230109138A (https=)
AU (1) AU2021361993A1 (https=)
CA (1) CA3195817A1 (https=)
IL (1) IL302148A (https=)
TW (1) TWI907544B (https=)
WO (1) WO2022082059A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250006910A (ko) * 2022-04-20 2025-01-13 센티 바이오사이언시스, 인코포레이티드 항원 결합 도메인 및 이의 사용 방법
WO2025085867A1 (en) * 2023-10-20 2025-04-24 A2 Biotherapeutics, Inc. Compositions and methods for treating blood cancers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6199054B2 (ja) * 2013-03-19 2017-09-20 公益財団法人かずさDna研究所 抗イヌIgEモノクローナル抗体並びに抗イヌIgEモノクローナル抗体の重鎖可変領域及び軽鎖可変領域
BR112016025450A2 (pt) * 2014-05-02 2017-12-12 Medimmune Ltd moduladores de canais de íons e usos dos mesmos
WO2017173327A1 (en) * 2016-03-31 2017-10-05 The Schepens Eye Research Institute, Inc. Endomucin inhibitor as an anti-angiogenic agent
US20200316120A1 (en) * 2018-09-28 2020-10-08 Immpact-Bio Ltd. METHODS FOR IDENTIFYING ACTIVATING ANTIGEN RECEPTOR (aCAR)/INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR) PAIRS FOR USE IN CANCER THERAPIES
EP3962527A4 (en) * 2019-04-30 2023-11-01 Senti Biosciences, Inc. CHIMERIC RECEPTORS AND METHODS OF USE THEREOF
CN115298209A (zh) * 2020-02-20 2022-11-04 森迪生物科学公司 抑制性嵌合受体构造体

Similar Documents

Publication Publication Date Title
CL2025004052A1 (es) Derivados pirazolo[3,2-c]piridinona, inhibidores egfr y/o her2; composición; uso en cáncer
JP2023515471A5 (https=)
JP2023545517A5 (https=)
CN306015502S (https=)
CN305998014S (https=)
CN305536720S (https=)
CN305535643S (https=)
CN305579715S (https=)
CN305535305S (https=)
CN305535268S (https=)
CN305534895S (https=)
CN305533241S (https=)
CN305531297S (https=)
CN305531138S (https=)
CN305530837S (https=)
CN305579556S (https=)
CN305529979S (https=)
CN305529160S (https=)
CN305528869S (https=)
CN305527498S (https=)
CN305578280S (https=)
CN305527018S (https=)
CN306274930S (https=)
CN306044013S (https=)
CN306042085S (https=)